Insulet Corporation Investor Alert: Contact SBS by August 31, 2026 for Opportunity to Lead Securities Fraud Lawsuit

Schall Brown & Schwartz LLP , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Insulet Corporation ("Insulet" or "the Company") (NASDAQ: PODD ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of PODD during the class period listed are encouraged to contact SBS to find out if they are eligible to recover their losses or lead this lawsuit.

Appointment as lead plaintiff is not required to partake in any recovery.

A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

CLASS PERIOD: February 21, 2025 to May 26, 2026

DEADLINE: August 31, 2026

According to the Complaint, the Company made false and misleading statements to the market.

Insulet suffered from defective controls over its manufacturing processes.

The Company faced increased risks of safety violations due to these deficiencies.

The Company's manufacturing problem necessitating its March 2026 Medical Device Cirrection impacted a greater number of its Pod Products than it claimed.

Based on these facts, the Company's public statements were false and materially misleading throughout the class period.

When the market learned the truth about Insulet, investors suffered damages.